0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Branded Generics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-18J8077
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Branded Generics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Branded Generics Market Research Report 2024

Code: QYRE-Auto-18J8077
Report
January 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Branded Generics Market Size

The global Branded Generics market was valued at US$ 312 million in 2023 and is anticipated to reach US$ 523.1 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.

Branded Generics Market

Branded Generics Market

This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Branded Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Branded Generics.

Report Scope

The Branded Generics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Branded Generics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Branded Generics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Branded Generics Market Report

Report Metric Details
Report Name Branded Generics Market
Accounted market size in 2023 US$ 312 million
Forecasted market size in 2030 US$ 523.1 million
CAGR 8.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Oral
  • Parenteral
  • Topical
  • Other
Segment by Application
  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Branded Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Branded Generics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Branded Generics Market growing?

Ans: The Branded Generics Market witnessing a CAGR of 8.2% during the forecast period 2024-2030.

What is the Branded Generics Market size in 2030?

Ans: The Branded Generics Market size in 2030 will be US$ 523.1 million.

Who are the main players in the Branded Generics Market report?

Ans: The main players in the Branded Generics Market are Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health

What are the Application segmentation covered in the Branded Generics Market report?

Ans: The Applications covered in the Branded Generics Market report are Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the Branded Generics Market report?

Ans: The Types covered in the Branded Generics Market report are Oral, Parenteral, Topical, Other

1 Branded Generics Market Overview
1.1 Product Overview and Scope of Branded Generics
1.2 Branded Generics Segment by Type
1.2.1 Global Branded Generics Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Topical
1.2.5 Other
1.3 Branded Generics Segment by Application
1.3.1 Global Branded Generics Market Value by Application: (2024-2030)
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Neurology
1.3.6 Gastrointestinal Diseases
1.3.7 Others
1.4 Global Branded Generics Market Size Estimates and Forecasts
1.4.1 Global Branded Generics Revenue 2019-2030
1.4.2 Global Branded Generics Sales 2019-2030
1.4.3 Global Branded Generics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Branded Generics Market Competition by Manufacturers
2.1 Global Branded Generics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Branded Generics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Branded Generics Average Price by Manufacturers (2019-2024)
2.4 Global Branded Generics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Branded Generics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Branded Generics, Product Type & Application
2.7 Branded Generics Market Competitive Situation and Trends
2.7.1 Branded Generics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Branded Generics Players Market Share by Revenue
2.7.3 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Branded Generics Retrospective Market Scenario by Region
3.1 Global Branded Generics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Branded Generics Global Branded Generics Sales by Region: 2019-2030
3.2.1 Global Branded Generics Sales by Region: 2019-2024
3.2.2 Global Branded Generics Sales by Region: 2025-2030
3.3 Global Branded Generics Global Branded Generics Revenue by Region: 2019-2030
3.3.1 Global Branded Generics Revenue by Region: 2019-2024
3.3.2 Global Branded Generics Revenue by Region: 2025-2030
3.4 North America Branded Generics Market Facts & Figures by Country
3.4.1 North America Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Branded Generics Sales by Country (2019-2030)
3.4.3 North America Branded Generics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Branded Generics Market Facts & Figures by Country
3.5.1 Europe Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Branded Generics Sales by Country (2019-2030)
3.5.3 Europe Branded Generics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Branded Generics Market Facts & Figures by Country
3.6.1 Asia Pacific Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Branded Generics Sales by Country (2019-2030)
3.6.3 Asia Pacific Branded Generics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Branded Generics Market Facts & Figures by Country
3.7.1 Latin America Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Branded Generics Sales by Country (2019-2030)
3.7.3 Latin America Branded Generics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Branded Generics Market Facts & Figures by Country
3.8.1 Middle East and Africa Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Branded Generics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Branded Generics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Branded Generics Sales by Type (2019-2030)
4.1.1 Global Branded Generics Sales by Type (2019-2024)
4.1.2 Global Branded Generics Sales by Type (2025-2030)
4.1.3 Global Branded Generics Sales Market Share by Type (2019-2030)
4.2 Global Branded Generics Revenue by Type (2019-2030)
4.2.1 Global Branded Generics Revenue by Type (2019-2024)
4.2.2 Global Branded Generics Revenue by Type (2025-2030)
4.2.3 Global Branded Generics Revenue Market Share by Type (2019-2030)
4.3 Global Branded Generics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Branded Generics Sales by Application (2019-2030)
5.1.1 Global Branded Generics Sales by Application (2019-2024)
5.1.2 Global Branded Generics Sales by Application (2025-2030)
5.1.3 Global Branded Generics Sales Market Share by Application (2019-2030)
5.2 Global Branded Generics Revenue by Application (2019-2030)
5.2.1 Global Branded Generics Revenue by Application (2019-2024)
5.2.2 Global Branded Generics Revenue by Application (2025-2030)
5.2.3 Global Branded Generics Revenue Market Share by Application (2019-2030)
5.3 Global Branded Generics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan NV
6.1.1 Mylan NV Corporation Information
6.1.2 Mylan NV Description and Business Overview
6.1.3 Mylan NV Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan NV Branded Generics Product Portfolio
6.1.5 Mylan NV Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis AG Branded Generics Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Eva Pharmaceutical Industries
6.3.1 Eva Pharmaceutical Industries Corporation Information
6.3.2 Eva Pharmaceutical Industries Description and Business Overview
6.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eva Pharmaceutical Industries Branded Generics Product Portfolio
6.3.5 Eva Pharmaceutical Industries Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Branded Generics Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Industries Branded Generics Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Aspen Pharmacare Holding
6.6.1 Aspen Pharmacare Holding Corporation Information
6.6.2 Aspen Pharmacare Holding Description and Business Overview
6.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aspen Pharmacare Holding Branded Generics Product Portfolio
6.6.5 Aspen Pharmacare Holding Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Branded Generics Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Bausch Health
6.8.1 Bausch Health Corporation Information
6.8.2 Bausch Health Description and Business Overview
6.8.3 Bausch Health Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bausch Health Branded Generics Product Portfolio
6.8.5 Bausch Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Branded Generics Industry Chain Analysis
7.2 Branded Generics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Branded Generics Production Mode & Process
7.4 Branded Generics Sales and Marketing
7.4.1 Branded Generics Sales Channels
7.4.2 Branded Generics Distributors
7.5 Branded Generics Customers
8 Branded Generics Market Dynamics
8.1 Branded Generics Industry Trends
8.2 Branded Generics Market Drivers
8.3 Branded Generics Market Challenges
8.4 Branded Generics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Branded Generics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Branded Generics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Branded Generics Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Branded Generics Sales (K MT) of Key Manufacturers (2019-2024)
    Table 5. Global Branded Generics Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Branded Generics Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Branded Generics Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Branded Generics Average Price (USD/MT) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Branded Generics, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Branded Generics, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Branded Generics, Product Type & Application
    Table 12. Global Key Manufacturers of Branded Generics, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Branded Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Branded Generics as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Branded Generics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Branded Generics Sales by Region (2019-2024) & (K MT)
    Table 18. Global Branded Generics Sales Market Share by Region (2019-2024)
    Table 19. Global Branded Generics Sales by Region (2025-2030) & (K MT)
    Table 20. Global Branded Generics Sales Market Share by Region (2025-2030)
    Table 21. Global Branded Generics Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Branded Generics Revenue Market Share by Region (2019-2024)
    Table 23. Global Branded Generics Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Branded Generics Revenue Market Share by Region (2025-2030)
    Table 25. North America Branded Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Branded Generics Sales by Country (2019-2024) & (K MT)
    Table 27. North America Branded Generics Sales by Country (2025-2030) & (K MT)
    Table 28. North America Branded Generics Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Branded Generics Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Branded Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Branded Generics Sales by Country (2019-2024) & (K MT)
    Table 32. Europe Branded Generics Sales by Country (2025-2030) & (K MT)
    Table 33. Europe Branded Generics Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Branded Generics Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Branded Generics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Branded Generics Sales by Region (2019-2024) & (K MT)
    Table 37. Asia Pacific Branded Generics Sales by Region (2025-2030) & (K MT)
    Table 38. Asia Pacific Branded Generics Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Branded Generics Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Branded Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Branded Generics Sales by Country (2019-2024) & (K MT)
    Table 42. Latin America Branded Generics Sales by Country (2025-2030) & (K MT)
    Table 43. Latin America Branded Generics Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Branded Generics Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Branded Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Branded Generics Sales by Country (2019-2024) & (K MT)
    Table 47. Middle East & Africa Branded Generics Sales by Country (2025-2030) & (K MT)
    Table 48. Middle East & Africa Branded Generics Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Branded Generics Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Branded Generics Sales (K MT) by Type (2019-2024)
    Table 51. Global Branded Generics Sales (K MT) by Type (2025-2030)
    Table 52. Global Branded Generics Sales Market Share by Type (2019-2024)
    Table 53. Global Branded Generics Sales Market Share by Type (2025-2030)
    Table 54. Global Branded Generics Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Branded Generics Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Branded Generics Revenue Market Share by Type (2019-2024)
    Table 57. Global Branded Generics Revenue Market Share by Type (2025-2030)
    Table 58. Global Branded Generics Price (USD/MT) by Type (2019-2024)
    Table 59. Global Branded Generics Price (USD/MT) by Type (2025-2030)
    Table 60. Global Branded Generics Sales (K MT) by Application (2019-2024)
    Table 61. Global Branded Generics Sales (K MT) by Application (2025-2030)
    Table 62. Global Branded Generics Sales Market Share by Application (2019-2024)
    Table 63. Global Branded Generics Sales Market Share by Application (2025-2030)
    Table 64. Global Branded Generics Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Branded Generics Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Branded Generics Revenue Market Share by Application (2019-2024)
    Table 67. Global Branded Generics Revenue Market Share by Application (2025-2030)
    Table 68. Global Branded Generics Price (USD/MT) by Application (2019-2024)
    Table 69. Global Branded Generics Price (USD/MT) by Application (2025-2030)
    Table 70. Mylan NV Corporation Information
    Table 71. Mylan NV Description and Business Overview
    Table 72. Mylan NV Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 73. Mylan NV Branded Generics Product
    Table 74. Mylan NV Recent Developments/Updates
    Table 75. Novartis AG Corporation Information
    Table 76. Novartis AG Description and Business Overview
    Table 77. Novartis AG Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 78. Novartis AG Branded Generics Product
    Table 79. Novartis AG Recent Developments/Updates
    Table 80. Eva Pharmaceutical Industries Corporation Information
    Table 81. Eva Pharmaceutical Industries Description and Business Overview
    Table 82. Eva Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 83. Eva Pharmaceutical Industries Branded Generics Product
    Table 84. Eva Pharmaceutical Industries Recent Developments/Updates
    Table 85. Pfizer Corporation Information
    Table 86. Pfizer Description and Business Overview
    Table 87. Pfizer Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 88. Pfizer Branded Generics Product
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Sun Pharmaceutical Industries Corporation Information
    Table 91. Sun Pharmaceutical Industries Description and Business Overview
    Table 92. Sun Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 93. Sun Pharmaceutical Industries Branded Generics Product
    Table 94. Sun Pharmaceutical Industries Recent Developments/Updates
    Table 95. Aspen Pharmacare Holding Corporation Information
    Table 96. Aspen Pharmacare Holding Description and Business Overview
    Table 97. Aspen Pharmacare Holding Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 98. Aspen Pharmacare Holding Branded Generics Product
    Table 99. Aspen Pharmacare Holding Recent Developments/Updates
    Table 100. Abbott Laboratories Corporation Information
    Table 101. Abbott Laboratories Description and Business Overview
    Table 102. Abbott Laboratories Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 103. Abbott Laboratories Branded Generics Product
    Table 104. Abbott Laboratories Recent Developments/Updates
    Table 105. Bausch Health Corporation Information
    Table 106. Bausch Health Description and Business Overview
    Table 107. Bausch Health Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 108. Bausch Health Branded Generics Product
    Table 109. Bausch Health Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Branded Generics Distributors List
    Table 113. Branded Generics Customers List
    Table 114. Branded Generics Market Trends
    Table 115. Branded Generics Market Drivers
    Table 116. Branded Generics Market Challenges
    Table 117. Branded Generics Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Branded Generics
    Figure 2. Global Branded Generics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Branded Generics Market Share by Type in 2023 & 2030
    Figure 4. Oral Product Picture
    Figure 5. Parenteral Product Picture
    Figure 6. Topical Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Branded Generics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Branded Generics Market Share by Application in 2023 & 2030
    Figure 10. Oncology
    Figure 11. Cardiovascular Diseases
    Figure 12. Diabetes
    Figure 13. Neurology
    Figure 14. Gastrointestinal Diseases
    Figure 15. Others
    Figure 16. Global Branded Generics Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Branded Generics Market Size (2019-2030) & (US$ Million)
    Figure 18. Global Branded Generics Sales (2019-2030) & (K MT)
    Figure 19. Global Branded Generics Average Price (USD/MT) & (2019-2030)
    Figure 20. Branded Generics Report Years Considered
    Figure 21. Branded Generics Sales Share by Manufacturers in 2023
    Figure 22. Global Branded Generics Revenue Share by Manufacturers in 2023
    Figure 23. The Global 5 and 10 Largest Branded Generics Players: Market Share by Revenue in 2023
    Figure 24. Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 25. Global Branded Generics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 26. North America Branded Generics Sales Market Share by Country (2019-2030)
    Figure 27. North America Branded Generics Revenue Market Share by Country (2019-2030)
    Figure 28. U.S. Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Canada Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Europe Branded Generics Sales Market Share by Country (2019-2030)
    Figure 31. Europe Branded Generics Revenue Market Share by Country (2019-2030)
    Figure 32. Germany Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. France Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. U.K. Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Italy Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Russia Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Branded Generics Sales Market Share by Region (2019-2030)
    Figure 38. Asia Pacific Branded Generics Revenue Market Share by Region (2019-2030)
    Figure 39. China Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Japan Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. South Korea Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. India Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Australia Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Taiwan Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Indonesia Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Thailand Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Malaysia Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Philippines Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Latin America Branded Generics Sales Market Share by Country (2019-2030)
    Figure 50. Latin America Branded Generics Revenue Market Share by Country (2019-2030)
    Figure 51. Mexico Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Brazil Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Argentina Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Middle East & Africa Branded Generics Sales Market Share by Country (2019-2030)
    Figure 55. Middle East & Africa Branded Generics Revenue Market Share by Country (2019-2030)
    Figure 56. Turkey Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. U.A.E Branded Generics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 59. Global Sales Market Share of Branded Generics by Type (2019-2030)
    Figure 60. Global Revenue Market Share of Branded Generics by Type (2019-2030)
    Figure 61. Global Branded Generics Price (USD/MT) by Type (2019-2030)
    Figure 62. Global Sales Market Share of Branded Generics by Application (2019-2030)
    Figure 63. Global Revenue Market Share of Branded Generics by Application (2019-2030)
    Figure 64. Global Branded Generics Price (USD/MT) by Application (2019-2030)
    Figure 65. Branded Generics Value Chain
    Figure 66. Branded Generics Production Process
    Figure 67. Channels of Distribution (Direct Vs Distribution)
    Figure 68. Distributors Profiles
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS